Spero Therapeutics Inc (SPRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SPRO | AMGN | VRTX | BMY | REGN |
| Company | Spero Therapeutics Inc | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 1.6300 | 313.39 | 401.50 | 43.90 | 926.94 |
| High | 1.6494 | 322.60 | 405.67 | 44.33 | 955.69 |
| Low | 1.6200 | 308.82 | 397.59 | 43.69 | 926.94 |
| Last | 1.6300 | 309.50 | 401.98 | 43.87 | 954.47 |
| Change | +0.0200 | +31.11 | +1.82 | +0.17 | +16.86 |
| % Change | +1.24% | +11.17% | +0.45% | +0.39% | +1.80% |
| Volume | 83,010 | 7,939,909 | 622,976 | 7,899,435 | 296,218 |
| 20-Day Average Volume | 197,837 | 2,552,939 | 999,303 | 14,244,226 | 505,162 |
| Previous Close | 1.6100 | 278.39 | 400.16 | 43.70 | 937.61 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.5297 | 272.15 | 398.49 | 47.45 | 909.77 |
| 20-Day Raw Stochastic | 71.05% | 77.96% | 71.20% | 5.95% | 99.81% |
| 20-Day Relative Strength | 54.58% | 71.29% | 48.20% | 28.27% | 58.64% |
| Weighted Alpha | -3.41 | +32.44 | +14.86 | -36.99 | +26.34 |
| Today's Opinion | 56% Buy | 24% Buy | 8% Buy | 100% Sell | 72% Buy |
| Previous Opinion | 40% Buy | 16% Sell | 8% Buy | 88% Sell | 48% Buy |
| Last Month's Opinion | 88% Buy | 24% Sell | 24% Buy | 8% Sell | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +12.33% since 04/26/24 | +14.43% since 04/26/24 | +1.23% since 04/26/24 | -2.27% since 04/26/24 | +8.13% since 04/26/24 |
| Low | 1.4200 on 04/30/24 | 268.99 on 04/29/24 | 391.70 on 04/30/24 | 43.33 on 05/02/24 | 883.20 on 04/29/24 |
| High | 1.6700 on 05/02/24 | 322.60 on 05/03/24 | 406.95 on 05/01/24 | 45.38 on 04/29/24 | 955.20 on 05/03/24 |
| 1-Month | |||||
| %Chg | -8.38% since 04/03/24 | +12.58% since 04/03/24 | -1.58% since 04/03/24 | -16.00% since 04/03/24 | +0.43% since 04/03/24 |
| Low | 1.3700 on 04/22/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 43.33 on 05/02/24 | 875.22 on 04/26/24 |
| High | 1.8000 on 04/04/24 | 322.60 on 05/03/24 | 412.64 on 04/04/24 | 52.08 on 04/04/24 | 962.20 on 04/04/24 |
| 3-Month | |||||
| %Chg | +12.71% since 02/02/24 | -4.41% since 02/02/24 | -5.26% since 02/02/24 | -10.02% since 02/02/24 | +1.04% since 02/02/24 |
| Low | 1.3300 on 02/08/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 43.33 on 05/02/24 | 875.22 on 04/26/24 |
| High | 1.8900 on 03/14/24 | 329.72 on 02/05/24 | 437.00 on 02/27/24 | 55.03 on 03/13/24 | 998.33 on 02/28/24 |
| 6-Month | |||||
| %Chg | +37.82% since 11/03/23 | +14.49% since 11/03/23 | +6.95% since 11/03/23 | -17.02% since 11/03/23 | +16.91% since 11/03/23 |
| Low | 1.0400 on 11/09/23 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 43.33 on 05/02/24 | 783.57 on 11/10/23 |
| High | 1.8900 on 03/14/24 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 55.03 on 03/13/24 | 998.33 on 02/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 86,768 | 149,321,728 | 103,424,960 | 88,584,272 | 102,913,952 |
| Shares Outstanding, K | 53,893 | 536,376 | 258,459 | 2,027,100 | 109,762 |
| Annual Sales | 103,780,000 | 28,190,000,000 | 9,869,200,000 | 45,006,000,000 | 13,117,200,000 |
| Annual Net Income | 22,810,000 | 6,717,000,000 | 3,619,600,000 | 8,025,000,000 | 3,953,600,000 |
| Last Quarter Sales | 73,520,000 | 8,196,000,000 | 2,517,700,000 | 11,865,000,000 | 3,434,300,000 |
| Last Quarter Net Income | 51,190,000 | 767,000,000 | 968,800,000 | -11,911,000,000 | 1,159,600,000 |
| 60-Month Beta | 0.62 | 0.60 | 0.39 | 0.45 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.96 on 03/13/24 | 3.96 on 05/02/24 | 4.20 on 02/05/24 | -4.40 on 04/25/24 | 9.55 on 05/02/24 |
| Latest Earnings Date | 05/09/24 | 05/02/24 | 05/06/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | 0.600 on 04/04/24 | N/A |
| Next Ex-Dividends Date | 09/16/15 | 05/16/24 | N/A | 04/04/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 3.09 | 14.87 | 29.92 | 42.10 | 24.04 |